Featured Stories: Hematology
An innovative new immunotherapy program for patients with certain blood cancers has launched. Chimeric Antigen Receptor (CAR) T-cell therapy reprograms a patient’s own T-cells to target tumor antigens.
Two scientists at Yale are working to change the outcomes for Angioimmunoblastic T-cell lymphoma (AITL), a rare, fast-growing cancer typically diagnosed at an advanced stage.
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare cancer involving the skin, bone marrow, and lymph nodes.
When Marc St. Martin was diagnosed with cutaneous T-cell lymphoma (CTCL), he had no way of knowing the impact it would have throughout his family.
At the age of 23, Josh Scussell was starting his life, and like most people in their early twenties, cancer was the last thing on his mind.
Denise Iorio was faced with two treatment options when she was diagnosed with myelodysplastic syndrome (MDS), she could take medication to control symptoms, or undergo a stem cell transplant.
The team at the Survivorship Clinic helped Jody understand that you are not the same person you were the day before you got diagnosed.
After receiving treatment for melanoma, a bone marrow biopsy confirmed that John had another cancer: acute myeloid leukemia.